USANA Health Sciences, Inc. (NYSE:USNA) Q1 2025 Earnings Call Transcript
Operator: Greetings. Welcome to the USANA Health Sciences First Quarter Conference Call. At this time, all participants are in a listen-only mode.
Usana Health Sciences Inc (USNA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 1,095,186 | $29,537,166 | +1% | 0.1% |
| 2. | Royce & Associates Chuck Royce | 44,835 | $1,209,200 | +16% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.70 | 10,396 | Director | 10,921,609 | 2017-12-11 | Filing | |
| $70.70 | 824 | Director | 10,911,213 | 2017-12-08 | Filing | |
| $70.46 | 6,697 | Director | 10,910,389 | 2017-12-07 | Filing | |
| $70.70 | 1,200 | Director | 10,903,692 | 2017-12-06 | Filing | |
| $70.70 | 10,396 | Large Shareholder | 10,921,609 | 2017-12-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.82 | 674 | Director | 0 | 2025-05-05 | Filing | |
| $32.54 | 5,732 | Officer | 0 | 2025-03-12 | Filing | |
| $32.34 | 4,743 | Officer | 0 | 2025-03-12 | Filing | |
| $33.30 | 500 | Director | 4,026 | 2025-03-11 | Filing | |
| $32.98 | 3,234 | Officer | 12,775 | 2025-03-10 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,838,929 | $49,595,916 | 0% | |
| 2. | 1,373,908 | $37,054,298 | 0% | |
| 3. | 173,997 | $4,692,699 | 0% | |
| 4. | 127,494 | $3,438,513 | 0.01% | |
| 5. | 104,410 | $2,815,938 | 0% |
News See All
USANA Health Sciences, Inc. (NYSE:USNA) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the USANA Health Sciences Fourth Quarter Conference Call. At this time, all participants are in a listen-only mode.
USANA Health Sciences, Inc. (NYSE:USNA) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to today's Usana Health Sciences Third Quarter Earnings Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode.
USANA Health Sciences, Inc. (NYSE:USNA) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the USANA Health Sciences Second Quarter Earnings Call. My name is Jess, and I'll be your coordinator for today's event. Please note, this call is being recorded.
USANA Health Sciences, Inc. (NYSE:USNA) Q1 2024 Earnings Call Transcript
Operator: Hello and welcome to USANA Health Sciences First Quarter Earnings Call. My name is George. I'll be your coordinator for today's event. Please note, this conference is being recorded.
USANA Health Sciences, Inc. (NYSE:USNA) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to USANA Health Sciences Fourth Quarter and Fiscal Year 2023 Earnings Call. My name is Melissa, and I will be your coordinator for today’s event.
USANA Health Sciences, Inc. (NYSE:USNA) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to USANA Health Sciences' Third Quarter Earnings Call. My name is Valeria and I'll be your coordinator for today's event.
USANA Health Sciences, Inc. (NYSE:USNA) Q2 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to USANA Health Sciences Second Quarter Earnings Call. Today's call is being recorded. And now at this time, I'd like to turn the call over to Andrew Masuda.
5 Small Cap Consumer Staples Stocks Billionaires Are Loading Up On
In this piece, we will take a look at five small cap consumer staples stocks billionaires are loading up on.
USANA Health Sciences, Inc. (NYSE:USNA) Q1 2023 Earnings Call Transcript
Operator: Good day and welcome to today’s USANA Health Sciences First Quarter Earnings Call. This meeting is being recorded. At this time, I’d like to hand the call over to Andrew Masuda.